{"id":3725,"date":"2021-09-22T10:43:22","date_gmt":"2021-09-22T08:43:22","guid":{"rendered":"https:\/\/ehin.no\/2021\/?post_type=speaker&#038;p=3725"},"modified":"2021-09-23T14:01:37","modified_gmt":"2021-09-23T12:01:37","slug":"pal-hasvold","status":"publish","type":"speaker","link":"https:\/\/ehin.no\/2021\/en\/speakers\/pal-hasvold\/","title":{"rendered":"P\u00e5l Hasvold"},"content":{"rendered":"<p><strong>P\u00e5l<\/strong> Hasvold is heading the Nordic AstraZeneca Medical Evidence team of epidemiologists, statisticians and project managers responsible 40 &#8211; 50 ongoing RWE studies across the Nordics. The team is responsible for study concepts, statistical methods, protocol development, results interpretation and publication of studies.<\/p>\n<p>He has an extensive research record focused on the development for methods for the analysis and combination of different types of Real World Data including Electronic Healthcare Record data, Nation-wide Registers and Clinical Quality Registers data. He has over 30 publications in peer reviewed international journals. P\u00e5l holds a Master of Science in Pharmacy and a PhD in Pharmacoepidemiology from Oslo University, Norway.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>P\u00e5l Hasvold is heading the Nordic AstraZeneca Medical Evidence team of epidemiologists, statisticians and project managers responsible 40 &#8211; 50 ongoing RWE studies across the Nordics. The team is responsible for study concepts, statistical methods, protocol development, results interpretation and publication of studies. He has an extensive research record focused on the development for methods [&hellip;]<\/p>\n","protected":false},"featured_media":3726,"template":"","speakertype":[7],"class_list":["post-3725","speaker","type-speaker","status-publish","has-post-thumbnail","hentry","speakertype-moderator"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>P\u00e5l Hasvold - EHIN 2021<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"P\u00e5l Hasvold - EHIN 2021\" \/>\n<meta property=\"og:description\" content=\"P\u00e5l Hasvold is heading the Nordic AstraZeneca Medical Evidence team of epidemiologists, statisticians and project managers responsible 40 &#8211; 50 ongoing RWE studies across the Nordics. The team is responsible for study concepts, statistical methods, protocol development, results interpretation and publication of studies. He has an extensive research record focused on the development for methods [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/\" \/>\n<meta property=\"og:site_name\" content=\"EHIN 2021\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-23T12:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ehin.no\/2021\/wp-content\/uploads\/sites\/3\/2021\/09\/paalikkekvadratenda-e1632476503306.png\" \/>\n\t<meta property=\"og:image:width\" content=\"628\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ehin.no\\\/2021\\\/speakers\\\/pal-hasvold\\\/\",\"url\":\"https:\\\/\\\/ehin.no\\\/2021\\\/speakers\\\/pal-hasvold\\\/\",\"name\":\"P\u00e5l Hasvold - EHIN 2021\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ehin.no\\\/2021\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ehin.no\\\/2021\\\/speakers\\\/pal-hasvold\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ehin.no\\\/2021\\\/speakers\\\/pal-hasvold\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ehin.no\\\/2021\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2021\\\/09\\\/paalikkekvadratenda-e1632476503306.png\",\"datePublished\":\"2021-09-22T08:43:22+00:00\",\"dateModified\":\"2021-09-23T12:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ehin.no\\\/2021\\\/speakers\\\/pal-hasvold\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ehin.no\\\/2021\\\/speakers\\\/pal-hasvold\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ehin.no\\\/2021\\\/speakers\\\/pal-hasvold\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ehin.no\\\/2021\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2021\\\/09\\\/paalikkekvadratenda-e1632476503306.png\",\"contentUrl\":\"https:\\\/\\\/ehin.no\\\/2021\\\/wp-content\\\/uploads\\\/sites\\\/3\\\/2021\\\/09\\\/paalikkekvadratenda-e1632476503306.png\",\"width\":628,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ehin.no\\\/2021\\\/speakers\\\/pal-hasvold\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\\\/\\\/ehin.no\\\/2021\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"P\u00e5l Hasvold\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ehin.no\\\/2021\\\/#website\",\"url\":\"https:\\\/\\\/ehin.no\\\/2021\\\/\",\"name\":\"EHIN 2021\",\"description\":\"9. og 10. november 2021\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ehin.no\\\/2021\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"P\u00e5l Hasvold - EHIN 2021","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/","og_locale":"en_US","og_type":"article","og_title":"P\u00e5l Hasvold - EHIN 2021","og_description":"P\u00e5l Hasvold is heading the Nordic AstraZeneca Medical Evidence team of epidemiologists, statisticians and project managers responsible 40 &#8211; 50 ongoing RWE studies across the Nordics. The team is responsible for study concepts, statistical methods, protocol development, results interpretation and publication of studies. He has an extensive research record focused on the development for methods [&hellip;]","og_url":"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/","og_site_name":"EHIN 2021","article_modified_time":"2021-09-23T12:01:37+00:00","og_image":[{"width":628,"height":628,"url":"https:\/\/ehin.no\/2021\/wp-content\/uploads\/sites\/3\/2021\/09\/paalikkekvadratenda-e1632476503306.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/","url":"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/","name":"P\u00e5l Hasvold - EHIN 2021","isPartOf":{"@id":"https:\/\/ehin.no\/2021\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/#primaryimage"},"image":{"@id":"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/#primaryimage"},"thumbnailUrl":"https:\/\/ehin.no\/2021\/wp-content\/uploads\/sites\/3\/2021\/09\/paalikkekvadratenda-e1632476503306.png","datePublished":"2021-09-22T08:43:22+00:00","dateModified":"2021-09-23T12:01:37+00:00","breadcrumb":{"@id":"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/#primaryimage","url":"https:\/\/ehin.no\/2021\/wp-content\/uploads\/sites\/3\/2021\/09\/paalikkekvadratenda-e1632476503306.png","contentUrl":"https:\/\/ehin.no\/2021\/wp-content\/uploads\/sites\/3\/2021\/09\/paalikkekvadratenda-e1632476503306.png","width":628,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/ehin.no\/2021\/speakers\/pal-hasvold\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/ehin.no\/2021\/en\/"},{"@type":"ListItem","position":2,"name":"P\u00e5l Hasvold"}]},{"@type":"WebSite","@id":"https:\/\/ehin.no\/2021\/#website","url":"https:\/\/ehin.no\/2021\/","name":"EHIN 2021","description":"9. og 10. november 2021","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ehin.no\/2021\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"speaker_title":"AstraZeneca","_links":{"self":[{"href":"https:\/\/ehin.no\/2021\/en\/wp-json\/wp\/v2\/speaker\/3725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ehin.no\/2021\/en\/wp-json\/wp\/v2\/speaker"}],"about":[{"href":"https:\/\/ehin.no\/2021\/en\/wp-json\/wp\/v2\/types\/speaker"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ehin.no\/2021\/en\/wp-json\/wp\/v2\/media\/3726"}],"wp:attachment":[{"href":"https:\/\/ehin.no\/2021\/en\/wp-json\/wp\/v2\/media?parent=3725"}],"wp:term":[{"taxonomy":"speakertype","embeddable":true,"href":"https:\/\/ehin.no\/2021\/en\/wp-json\/wp\/v2\/speakertype?post=3725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}